comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Ensifentrine - Page 1 : comparemela.com
Verona Eyes New Milestones Ahead, Will The Stock Get A Boost?
After a year of remarkable achievements, Verona Pharma plc (VRNA) looks to make 2023 even more momentous..
Verona-pharma
New-drug-application
Copd
Anti-inflammatory
Bronchodilator
Stock-price
Exacerbations
Ensifentrine
Verona
Nhance-program
Verona Pharma's ensifentrine meets COPD objectives
Therapy shows quality of life boost and significant improvement in lung function - News - PharmaTimes
Texas
United-states
David-zaccardelli
Verona-pharma
Antonio-anzueto
South-texas-veterans-healthcare-system
Verona
Ensifentrine
Copd
Verona's ensifentrine meets primary endpoint
Chronic obstructive pulmonary disease phase 3 study shows statistically significant improvements in lung function - News - PharmaTimes
Texas
United-states
David-zaccardelli
Verona-pharma
Antonio-anzueto
South-texas-veterans-healthcare-system
Verona
Ensifentrine
Trial
Verona Pharma's ensifentrine heads for phase 3 chronic obstructive pulmonary disease trial
The company completes its enrolment in phase 3 trial evaluating ensifentrine for treatment of COPD - News - PharmaTimes
David-zaccardelli
Verona
Ensifentrine
Copd
Verona Pharma 和优锐医药宣布开展2.19亿美元的战略合作，在大中华区开发和商业化Ensifentrine-美通社PR-Newswire
伦敦和上海2021年6月10日 /美通社/ Verona Pharma plc（Nasdaq：VRNA）（
China
Shanghai
Hong-kong
London
City-of
United-kingdom
Macau
States-europe
Greater-china
Taiwan-hong-kong
United-states-europe
China-market
vimarsana © 2020. All Rights Reserved.